We Run For Hope 2018

Runners and walkers from around the city gathered at Flushing Meadows Park on Sunday, June 4, for the We Run for Hope 5K/10K Run and Walk. This event, held annually on National Cancer Survivors Day, is a great opportunity to support women with breast or ovarian cancer while also staying fit and active.

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery

Avastin is now approved for ten distinct uses across six different types of cancer in the United States.

SOUTH SAN FRANCISCO, Calif. – June 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection.

May 8 is World Ovarian Cancer Day!

On May 8, people around the world are gathering to support awareness of ovarian cancer. Join SHARE by following us on Facebook, Twitter, and Instagram, where we’ll be posting about signs, symptoms, and stories you can share with the women in your life.

SHARE’s Annual Volunteer Party

April is National Volunteer Appreciation Month, and SHARE hosted its annual volunteer party to show how much we appreciate the incredible commitment of our volunteers. It was another great gathering with a raffle, food, music, and of course, amazing company.

Announcing SHARE’s National Expansion

New Support Groups Active in Norwalk, CT; Brentwood, NY; and Orlando, FL
After 42 years in New York City, SHARE Cancer Support has announced a national expansion effort. Norwalk, CT; Brentwood, Long Island, NY; and Orlando, FL are the first cities outside New York City to offer SHARE’s in-person services to women with breast or ovarian cancers.

National Helpline:
844-ASK-SHARE